BridgeBio Oncology's Engagement at Important December Conferences
BridgeBio Oncology Therapeutics, Inc. (NASDAQ: BBOT), renowned for its focus on RAS-pathway malignancies, is gearing up for a significant month ahead. The leadership team of BBOT will be actively participating in two major investor conferences this December, aimed at enhancing visibility and discussing groundbreaking advancements in cancer therapies.
Details of the Upcoming Conferences
BBOT's participation in these investor conferences underscores its commitment to transparency and engagement with the financial community. Here are the important details:
- Piper Sandler 37th Annual Healthcare Conference
Presentation is scheduled for Tuesday, December 2, at 2:00 p.m. ET. - 8th Annual Evercore Healthcare Conference
Presentation will be held on Wednesday, December 3, at 9:35 a.m. ET.
For those unable to attend live, BBOT will offer webcasts of these presentations, which will be accessible on their official website. Replays of the webcasts will remain available for at least 90 days following each event, providing ample opportunity to catch up.
About BridgeBio Oncology
BridgeBio Oncology Therapeutics, Inc. is at the forefront of biopharmaceutical innovations, particularly in developing next-generation small molecule therapeutics aimed at combating cancers driven by RAS and PI3K?. This commitment to addressing some of the most pressing challenges in oncology showcases their dedication to improving patient outcomes. Interested individuals can find more information by visiting www.bbotx.com and connecting with them on social media platforms.
Company Contacts for Inquiries
For further details regarding investors and media, BridgeBio Oncology has designated points of contact to assist:
Investor Contact:
Heather Armstrong
Email: Heather.Armstrong@bbotx.com
Media Contact:
Jake Robison
Inizio Evoke Comms
Email: Jake.robison@inizioevoke.com
Frequently Asked Questions
What are the dates of the investor conferences BBOT is attending?
BBOT will participate in the Piper Sandler conference on December 2 and the Evercore conference on December 3.
Where can I watch the presentations for the conferences?
The presentations will be available via live webcast on the BBOT website, with replays accessible for 90 days after.
What is the focus of BridgeBio Oncology's research?
BBOT specializes in developing treatments targeting RAS and PI3K? malignancies to improve patient outcomes in oncology.
How can I contact BridgeBio Oncology for more information?
Contact Heather Armstrong for investor inquiries or Jake Robison for media questions via the provided email addresses.
Where can I find more information about BBOT's projects?
Visit BBOT's official website at www.bbotx.com for detailed insights into their projects and research developments.
